nodes	percent_of_prediction	percent_of_DWPC	metapath
Diphenhydramine—Captodiame—DRD3—attention deficit hyperactivity disorder	0.00597	0.0664	CrCbGaD
Diphenhydramine—Phenoxybenzamine—ADRA2C—attention deficit hyperactivity disorder	0.00466	0.0518	CrCbGaD
Diphenhydramine—Bepridil—CACNA1C—attention deficit hyperactivity disorder	0.00439	0.0488	CrCbGaD
Diphenhydramine—Diphenylpyraline—SLC6A3—attention deficit hyperactivity disorder	0.00431	0.0479	CrCbGaD
Diphenhydramine—Cinnarizine—CACNA1C—attention deficit hyperactivity disorder	0.004	0.0444	CrCbGaD
Diphenhydramine—Reboxetine—SLC6A4—attention deficit hyperactivity disorder	0.00391	0.0434	CrCbGaD
Diphenhydramine—Doxepin—ADRA2C—attention deficit hyperactivity disorder	0.00379	0.0421	CrCbGaD
Diphenhydramine—Benzatropine—SLC6A3—attention deficit hyperactivity disorder	0.0033	0.0367	CrCbGaD
Diphenhydramine—Chlorphenamine—SLC6A3—attention deficit hyperactivity disorder	0.0025	0.0278	CrCbGaD
Diphenhydramine—Modafinil—SLC6A3—attention deficit hyperactivity disorder	0.00245	0.0272	CrCbGaD
Diphenhydramine—Atomoxetine—HTR1B—attention deficit hyperactivity disorder	0.00233	0.0259	CrCbGaD
Diphenhydramine—Benzphetamine—SLC6A3—attention deficit hyperactivity disorder	0.00212	0.0236	CrCbGaD
Diphenhydramine—Atomoxetine—SLC6A3—attention deficit hyperactivity disorder	0.0021	0.0234	CrCbGaD
Diphenhydramine—Benzphetamine—ADRA2A—attention deficit hyperactivity disorder	0.00208	0.0231	CrCbGaD
Diphenhydramine—Cyclobenzaprine—HTR2A—attention deficit hyperactivity disorder	0.00206	0.0229	CrCbGaD
Diphenhydramine—Phenoxybenzamine—ADRA2A—attention deficit hyperactivity disorder	0.00199	0.0221	CrCbGaD
Diphenhydramine—CHRM2—forebrain—attention deficit hyperactivity disorder	0.00195	0.0754	CbGeAlD
Diphenhydramine—SLC22A1—forebrain—attention deficit hyperactivity disorder	0.00192	0.0741	CbGeAlD
Diphenhydramine—Chlorphenamine—SLC6A4—attention deficit hyperactivity disorder	0.00187	0.0208	CrCbGaD
Diphenhydramine—Promazine—DRD4—attention deficit hyperactivity disorder	0.00183	0.0203	CrCbGaD
Diphenhydramine—Cinnarizine—DRD2—attention deficit hyperactivity disorder	0.00176	0.0196	CrCbGaD
Diphenhydramine—Trimipramine—SLC6A3—attention deficit hyperactivity disorder	0.00173	0.0192	CrCbGaD
Diphenhydramine—Trimipramine—ADRA2A—attention deficit hyperactivity disorder	0.0017	0.0189	CrCbGaD
Diphenhydramine—CHRM2—cardiovascular system—attention deficit hyperactivity disorder	0.00165	0.0638	CbGeAlD
Diphenhydramine—Doxepin—ADRA2A—attention deficit hyperactivity disorder	0.00162	0.018	CrCbGaD
Diphenhydramine—Atomoxetine—SLC6A4—attention deficit hyperactivity disorder	0.00157	0.0175	CrCbGaD
Diphenhydramine—Promazine—DRD1—attention deficit hyperactivity disorder	0.00155	0.0172	CrCbGaD
Diphenhydramine—Promazine—ADRA2A—attention deficit hyperactivity disorder	0.00144	0.016	CrCbGaD
Diphenhydramine—Amitriptyline—HTR1B—attention deficit hyperactivity disorder	0.00141	0.0157	CrCbGaD
Diphenhydramine—CHRM2—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.00139	0.00157	CbGpPWpGaD
Diphenhydramine—CHRM2—G alpha (i) signalling events—DRD3—attention deficit hyperactivity disorder	0.00138	0.00156	CbGpPWpGaD
Diphenhydramine—SLC22A2—SLC-mediated transmembrane transport—SLC6A3—attention deficit hyperactivity disorder	0.00137	0.00155	CbGpPWpGaD
Diphenhydramine—Amitriptyline—DRD3—attention deficit hyperactivity disorder	0.00137	0.0152	CrCbGaD
Diphenhydramine—SLC22A1—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.00136	0.00153	CbGpPWpGaD
Diphenhydramine—CHRM2—G alpha (i) signalling events—ADRA2A—attention deficit hyperactivity disorder	0.00135	0.00153	CbGpPWpGaD
Diphenhydramine—HRH1—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.00134	0.00152	CbGpPWpGaD
Diphenhydramine—SLC22A1—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.00134	0.00152	CbGpPWpGaD
Diphenhydramine—CHRM2—G alpha (i) signalling events—DRD4—attention deficit hyperactivity disorder	0.00134	0.00151	CbGpPWpGaD
Diphenhydramine—HRH1—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.00134	0.00151	CbGpPWpGaD
Diphenhydramine—SLC22A1—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.00133	0.00151	CbGpPWpGaD
Diphenhydramine—CYP1A2—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.00132	0.0015	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.00132	0.00149	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.00131	0.00149	CbGpPWpGaD
Diphenhydramine—HRH1—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.0013	0.00147	CbGpPWpGaD
Diphenhydramine—SLC22A2—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.0013	0.00147	CbGpPWpGaD
Diphenhydramine—Trimipramine—SLC6A4—attention deficit hyperactivity disorder	0.00129	0.0144	CrCbGaD
Diphenhydramine—Trimipramine—DRD2—attention deficit hyperactivity disorder	0.00129	0.0143	CrCbGaD
Diphenhydramine—Imipramine—SLC6A3—attention deficit hyperactivity disorder	0.00128	0.0143	CrCbGaD
Diphenhydramine—CHRM2—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.00128	0.00145	CbGpPWpGaD
Diphenhydramine—SLC22A1—SLC-mediated transmembrane transport—SLC6A3—attention deficit hyperactivity disorder	0.00128	0.00145	CbGpPWpGaD
Diphenhydramine—HRH1—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.00128	0.00144	CbGpPWpGaD
Diphenhydramine—HRH1—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.00126	0.00143	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.00126	0.00142	CbGpPWpGaD
Diphenhydramine—Amitriptyline—ADRA2A—attention deficit hyperactivity disorder	0.00125	0.0139	CrCbGaD
Diphenhydramine—CHRM2—G alpha (i) signalling events—DRD2—attention deficit hyperactivity disorder	0.00125	0.00141	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.00124	0.0014	CbGpPWpGaD
Diphenhydramine—Promethazine—DRD2—attention deficit hyperactivity disorder	0.00124	0.0138	CrCbGaD
Diphenhydramine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.00124	0.0014	CbGpPWpGaD
Diphenhydramine—Doxepin—SLC6A4—attention deficit hyperactivity disorder	0.00123	0.0137	CrCbGaD
Diphenhydramine—Doxepin—DRD2—attention deficit hyperactivity disorder	0.00123	0.0136	CrCbGaD
Diphenhydramine—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.00122	0.00138	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.00121	0.00137	CbGpPWpGaD
Diphenhydramine—CHRM2—SIDS Susceptibility Pathways—HTR2A—attention deficit hyperactivity disorder	0.00121	0.00137	CbGpPWpGaD
Diphenhydramine—CYP1A2—Phase II conjugation—COMT—attention deficit hyperactivity disorder	0.00121	0.00137	CbGpPWpGaD
Diphenhydramine—Atomoxetine—HTR2A—attention deficit hyperactivity disorder	0.00121	0.0134	CrCbGaD
Diphenhydramine—SLC22A1—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.00121	0.00137	CbGpPWpGaD
Diphenhydramine—CYP2B6—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.0012	0.00136	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.00119	0.00135	CbGpPWpGaD
Diphenhydramine—CYP2B6—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.00119	0.00135	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.00119	0.00134	CbGpPWpGaD
Diphenhydramine—HRH1—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.00117	0.00133	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.00116	0.00131	CbGpPWpGaD
Diphenhydramine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.00115	0.0013	CbGpPWpGaD
Diphenhydramine—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.00113	0.00128	CbGpPWpGaD
Diphenhydramine—HRH1—forebrain—attention deficit hyperactivity disorder	0.00113	0.0437	CbGeAlD
Diphenhydramine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.00111	0.00126	CbGpPWpGaD
Diphenhydramine—SLC22A5—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.00111	0.00125	CbGpPWpGaD
Diphenhydramine—SLC22A2—Neuronal System—COMT—attention deficit hyperactivity disorder	0.0011	0.00125	CbGpPWpGaD
Diphenhydramine—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.0011	0.00124	CbGpPWpGaD
Diphenhydramine—SLC22A2—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.00109	0.00124	CbGpPWpGaD
Diphenhydramine—HRH1—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.00109	0.00124	CbGpPWpGaD
Diphenhydramine—Promazine—DRD2—attention deficit hyperactivity disorder	0.00109	0.0121	CrCbGaD
Diphenhydramine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.00108	0.00122	CbGpPWpGaD
Diphenhydramine—HRH1—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.00108	0.00122	CbGpPWpGaD
Diphenhydramine—CHRM2—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.00108	0.00122	CbGpPWpGaD
Diphenhydramine—HRH1—G alpha (q) signalling events—HTR2A—attention deficit hyperactivity disorder	0.00106	0.0012	CbGpPWpGaD
Diphenhydramine—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.00106	0.0012	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.00106	0.0012	CbGpPWpGaD
Diphenhydramine—CHRM2—nervous system—attention deficit hyperactivity disorder	0.00106	0.0409	CbGeAlD
Diphenhydramine—PTGS1—forebrain—attention deficit hyperactivity disorder	0.00105	0.0404	CbGeAlD
Diphenhydramine—SLC22A1—nervous system—attention deficit hyperactivity disorder	0.00104	0.0402	CbGeAlD
Diphenhydramine—SLC22A1—Neuronal System—COMT—attention deficit hyperactivity disorder	0.00103	0.00116	CbGpPWpGaD
Diphenhydramine—SLC22A1—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.00102	0.00115	CbGpPWpGaD
Diphenhydramine—CHRM2—central nervous system—attention deficit hyperactivity disorder	0.00102	0.0394	CbGeAlD
Diphenhydramine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.00101	0.00114	CbGpPWpGaD
Diphenhydramine—SLC22A1—central nervous system—attention deficit hyperactivity disorder	0.001	0.0387	CbGeAlD
Diphenhydramine—CYP2C18—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.001	0.00113	CbGpPWpGaD
Diphenhydramine—Trimipramine—HTR2A—attention deficit hyperactivity disorder	0.000994	0.0111	CrCbGaD
Diphenhydramine—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.00099	0.00112	CbGpPWpGaD
Diphenhydramine—CYP2B6—cardiovascular system—attention deficit hyperactivity disorder	0.000978	0.0378	CbGeAlD
Diphenhydramine—CYP2C9—cardiovascular system—attention deficit hyperactivity disorder	0.000968	0.0374	CbGeAlD
Diphenhydramine—Imipramine—SLC6A4—attention deficit hyperactivity disorder	0.00096	0.0107	CrCbGaD
Diphenhydramine—Promethazine—HTR2A—attention deficit hyperactivity disorder	0.000958	0.0106	CrCbGaD
Diphenhydramine—Imipramine—DRD2—attention deficit hyperactivity disorder	0.000954	0.0106	CrCbGaD
Diphenhydramine—Amitriptyline—SLC6A4—attention deficit hyperactivity disorder	0.000954	0.0106	CrCbGaD
Diphenhydramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—attention deficit hyperactivity disorder	0.000952	0.00108	CbGpPWpGaD
Diphenhydramine—Amitriptyline—DRD2—attention deficit hyperactivity disorder	0.000948	0.0105	CrCbGaD
Diphenhydramine—Doxepin—HTR2A—attention deficit hyperactivity disorder	0.000948	0.0105	CrCbGaD
Diphenhydramine—HRH1—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.000941	0.00106	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.000926	0.00105	CbGpPWpGaD
Diphenhydramine—CYP2C19—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000908	0.00103	CbGpPWpGaD
Diphenhydramine—CYP2C19—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000902	0.00102	CbGpPWpGaD
Diphenhydramine—HRH1—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.000896	0.00101	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000896	0.00101	CbGpPWpGaD
Diphenhydramine—PTGS1—cardiovascular system—attention deficit hyperactivity disorder	0.000884	0.0342	CbGeAlD
Diphenhydramine—CHRM2—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.000882	0.000997	CbGpPWpGaD
Diphenhydramine—SLC22A5—midbrain—attention deficit hyperactivity disorder	0.000879	0.034	CbGeAlD
Diphenhydramine—HRH1—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.000878	0.000993	CbGpPWpGaD
Diphenhydramine—HRH1—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.000875	0.00099	CbGpPWpGaD
Diphenhydramine—CYP1A2—Aryl Hydrocarbon Receptor—EP300—attention deficit hyperactivity disorder	0.000872	0.000986	CbGpPWpGaD
Diphenhydramine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—attention deficit hyperactivity disorder	0.000872	0.000986	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.000864	0.000977	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.000861	0.000974	CbGpPWpGaD
Diphenhydramine—CYP2D6—forebrain—attention deficit hyperactivity disorder	0.000859	0.0332	CbGeAlD
Diphenhydramine—HRH1—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.000848	0.000959	CbGpPWpGaD
Diphenhydramine—Promazine—HTR2A—attention deficit hyperactivity disorder	0.000842	0.00937	CrCbGaD
Diphenhydramine—CYP2D6—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000835	0.000945	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.000834	0.000943	CbGpPWpGaD
Diphenhydramine—HRH1—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.000833	0.000942	CbGpPWpGaD
Diphenhydramine—CYP2D6—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.00083	0.000938	CbGpPWpGaD
Diphenhydramine—CYP2C9—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000828	0.000937	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000824	0.000932	CbGpPWpGaD
Diphenhydramine—HRH1—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.000823	0.000931	CbGpPWpGaD
Diphenhydramine—HRH1—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.000823	0.000931	CbGpPWpGaD
Diphenhydramine—CYP2C9—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000822	0.00093	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.00082	0.000927	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000817	0.000924	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.000814	0.000921	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.00081	0.000916	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.00081	0.000916	CbGpPWpGaD
Diphenhydramine—CHRM2—brain—attention deficit hyperactivity disorder	0.00081	0.0313	CbGeAlD
Diphenhydramine—CHRM2—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.000801	0.000906	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.000797	0.000902	CbGpPWpGaD
Diphenhydramine—SLC22A1—brain—attention deficit hyperactivity disorder	0.000795	0.0307	CbGeAlD
Diphenhydramine—CHRM2—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.000785	0.000887	CbGpPWpGaD
Diphenhydramine—HRH1—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.000767	0.000867	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.000754	0.000853	CbGpPWpGaD
Diphenhydramine—Imipramine—HTR2A—attention deficit hyperactivity disorder	0.000738	0.0082	CrCbGaD
Diphenhydramine—Amitriptyline—HTR2A—attention deficit hyperactivity disorder	0.000733	0.00815	CrCbGaD
Diphenhydramine—HRH1—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.000717	0.000811	CbGpPWpGaD
Diphenhydramine—CYP1A2—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000708	0.0008	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.000705	0.000798	CbGpPWpGaD
Diphenhydramine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.000705	0.000797	CbGpPWpGaD
Diphenhydramine—CYP1A2—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000703	0.000795	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000698	0.000789	CbGpPWpGaD
Diphenhydramine—SLC22A2—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000697	0.000788	CbGpPWpGaD
Diphenhydramine—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.000694	0.000785	CbGpPWpGaD
Diphenhydramine—CYP2C18—Metabolism—TPH2—attention deficit hyperactivity disorder	0.00069	0.00078	CbGpPWpGaD
Diphenhydramine—CYP2C18—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.00069	0.00078	CbGpPWpGaD
Diphenhydramine—SLC22A5—cerebellum—attention deficit hyperactivity disorder	0.00068	0.0263	CbGeAlD
Diphenhydramine—CYP2C18—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000679	0.000768	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000664	0.000751	CbGpPWpGaD
Diphenhydramine—SLC22A1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.00065	0.000735	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000644	0.000729	CbGpPWpGaD
Diphenhydramine—CHRM2—SIDS Susceptibility Pathways—EP300—attention deficit hyperactivity disorder	0.000642	0.000726	CbGpPWpGaD
Diphenhydramine—CYP2C18—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000631	0.000714	CbGpPWpGaD
Diphenhydramine—CYP2B6—nervous system—attention deficit hyperactivity disorder	0.000628	0.0243	CbGeAlD
Diphenhydramine—SLC22A1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000619	0.0007	CbGpPWpGaD
Diphenhydramine—HRH1—nervous system—attention deficit hyperactivity disorder	0.000613	0.0237	CbGeAlD
Diphenhydramine—HRH1—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.000609	0.000688	CbGpPWpGaD
Diphenhydramine—CYP2B6—central nervous system—attention deficit hyperactivity disorder	0.000604	0.0234	CbGeAlD
Diphenhydramine—CHRM2—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.000599	0.000677	CbGpPWpGaD
Diphenhydramine—HRH1—central nervous system—attention deficit hyperactivity disorder	0.00059	0.0228	CbGeAlD
Diphenhydramine—PTGS1—nervous system—attention deficit hyperactivity disorder	0.000568	0.0219	CbGeAlD
Diphenhydramine—HRH1—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.00056	0.000633	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.000553	0.000625	CbGpPWpGaD
Diphenhydramine—SLC22A5—brain—attention deficit hyperactivity disorder	0.000553	0.0214	CbGeAlD
Diphenhydramine—CYP2C18—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000552	0.000624	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000551	0.000623	CbGpPWpGaD
Diphenhydramine—PTGS1—central nervous system—attention deficit hyperactivity disorder	0.000546	0.0211	CbGeAlD
Diphenhydramine—CHRM2—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.000544	0.000615	CbGpPWpGaD
Diphenhydramine—HRH1—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.000537	0.000607	CbGpPWpGaD
Diphenhydramine—HRH1—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.000532	0.000602	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.000528	0.000597	CbGpPWpGaD
Diphenhydramine—CYP2C18—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000525	0.000594	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.000523	0.000592	CbGpPWpGaD
Diphenhydramine—HRH1—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.000495	0.000559	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000492	0.000556	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.000487	0.00055	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000483	0.000546	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000481	0.000544	CbGpPWpGaD
Diphenhydramine—CYP2B6—brain—attention deficit hyperactivity disorder	0.00048	0.0186	CbGeAlD
Diphenhydramine—HRH1—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000479	0.000542	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000475	0.000538	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000473	0.000535	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000471	0.000533	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000471	0.000533	CbGpPWpGaD
Diphenhydramine—HRH1—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000471	0.000532	CbGpPWpGaD
Diphenhydramine—HRH1—brain—attention deficit hyperactivity disorder	0.000469	0.0181	CbGeAlD
Diphenhydramine—CYP2D6—nervous system—attention deficit hyperactivity disorder	0.000466	0.018	CbGeAlD
Diphenhydramine—HRH1—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000465	0.000526	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000464	0.000524	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000463	0.000524	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000462	0.000522	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000458	0.000518	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000458	0.000518	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000458	0.000517	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000455	0.000514	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000451	0.00051	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000449	0.000508	CbGpPWpGaD
Diphenhydramine—CYP2D6—central nervous system—attention deficit hyperactivity disorder	0.000449	0.0174	CbGeAlD
Diphenhydramine—PTGS1—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000445	0.000503	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000445	0.000503	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000442	0.0005	CbGpPWpGaD
Diphenhydramine—CYP2D6—cerebellum—attention deficit hyperactivity disorder	0.000439	0.017	CbGeAlD
Diphenhydramine—PTGS1—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000437	0.000495	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000435	0.000492	CbGpPWpGaD
Diphenhydramine—PTGS1—brain—attention deficit hyperactivity disorder	0.000434	0.0168	CbGeAlD
Diphenhydramine—HRH1—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000433	0.00049	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000428	0.000484	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000428	0.000484	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000427	0.000483	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000427	0.000483	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000426	0.000482	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000422	0.000478	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000421	0.000476	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—DPYD—attention deficit hyperactivity disorder	0.00042	0.000475	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000419	0.000474	CbGpPWpGaD
Diphenhydramine—CYP2C18—Metabolism—COMT—attention deficit hyperactivity disorder	0.000418	0.000473	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000416	0.00047	CbGpPWpGaD
Diphenhydramine—CYP2C18—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000415	0.00047	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000407	0.00046	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000393	0.000445	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.00039	0.000442	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000387	0.000438	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000371	0.00042	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000366	0.000414	CbGpPWpGaD
Diphenhydramine—CYP2D6—brain—attention deficit hyperactivity disorder	0.000357	0.0138	CbGeAlD
Diphenhydramine—PTGS1—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000355	0.000402	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000349	0.000394	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000342	0.000386	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000341	0.000386	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000339	0.000384	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000339	0.000384	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000339	0.000383	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000338	0.000383	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000334	0.000377	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000327	0.000369	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000325	0.000367	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000321	0.000363	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.00031	0.000351	CbGpPWpGaD
Diphenhydramine—HRH1—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000303	0.000343	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000299	0.000338	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000289	0.000327	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000285	0.000323	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000281	0.000318	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—COMT—attention deficit hyperactivity disorder	0.000278	0.000314	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000276	0.000312	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000276	0.000312	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000271	0.000307	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000271	0.000307	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—COMT—attention deficit hyperactivity disorder	0.000269	0.000305	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000268	0.000303	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000265	0.0003	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000261	0.000295	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000259	0.000293	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—COMT—attention deficit hyperactivity disorder	0.000259	0.000293	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000258	0.000292	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000257	0.000291	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000257	0.00029	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000256	0.00029	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000256	0.00029	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000253	0.000286	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000253	0.000286	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000252	0.000285	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000249	0.000282	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000249	0.000281	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000245	0.000278	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000236	0.000267	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000236	0.000267	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000234	0.000265	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000234	0.000264	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000234	0.000264	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000232	0.000263	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000232	0.000262	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—DPYD—attention deficit hyperactivity disorder	0.00023	0.00026	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000229	0.000259	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000216	0.000244	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000214	0.000242	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—COMT—attention deficit hyperactivity disorder	0.000206	0.000232	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000205	0.000232	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000204	0.000231	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—TPH2—attention deficit hyperactivity disorder	0.0002	0.000226	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.0002	0.000226	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000197	0.000222	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000195	0.000221	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000189	0.000213	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000187	0.000211	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000183	0.000207	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000179	0.000203	CbGpPWpGaD
Diphenhydramine—CYP2C18—Metabolism—EP300—attention deficit hyperactivity disorder	0.000179	0.000203	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000178	0.000201	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000163	0.000184	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.00016	0.000181	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.00016	0.000181	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—COMT—attention deficit hyperactivity disorder	0.000155	0.000176	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000154	0.000174	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000152	0.000172	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.00015	0.000169	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—COMT—attention deficit hyperactivity disorder	0.000143	0.000162	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000142	0.00016	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—COMT—attention deficit hyperactivity disorder	0.000142	0.00016	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000141	0.000159	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000136	0.000154	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—COMT—attention deficit hyperactivity disorder	0.000121	0.000137	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—MAOA—attention deficit hyperactivity disorder	0.00012	0.000136	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—EP300—attention deficit hyperactivity disorder	0.000119	0.000135	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000117	0.000132	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—EP300—attention deficit hyperactivity disorder	0.000116	0.000131	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—EP300—attention deficit hyperactivity disorder	0.000111	0.000125	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—EP300—attention deficit hyperactivity disorder	8.81e-05	9.97e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	8.62e-05	9.75e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—EP300—attention deficit hyperactivity disorder	8.48e-05	9.6e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—EP300—attention deficit hyperactivity disorder	6.66e-05	7.53e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—EP300—attention deficit hyperactivity disorder	6.13e-05	6.93e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—EP300—attention deficit hyperactivity disorder	6.07e-05	6.87e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—EP300—attention deficit hyperactivity disorder	5.19e-05	5.87e-05	CbGpPWpGaD
